Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 18, 2024Sri Lankan Journal of Infectious DiseasesOpen Access

Clinical characteristics and analysis of treatment outcome at one year of rhino-orbito-cerebral mucormycosis cases during the second wave of the Covid-19 pandemic (2nd wave); experiences from a tertiary care hospital in Kolkata, India

View Full Paper
Ask AI
Bookmark
Share

Authors

DMDolan Champa ModakSGSubhasish Kamal GuhaDMD Majumdar

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Modak et al. (2024) studied this question.

synapsesocial.com/papers/68e5fee2b6db643587592558https://doi.org/10.4038/sljid.v14i2.8661
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The COVID-19 Pandemic and the Escalation of Rhino-Orbital-Cerebral Mucormycosis: A Retrospective Review2025
  2. 2Scenario of mucormycosis in COVID-19 pandemic era from a tertiary care center in West Bengal2026
  3. 3Survival from rhino-orbital-cerebral mucormycosis in SARS-COV-2 positive diabetic patients: Two case reports2024 · 2 citations
  4. 4An Experience with Post Covid-19 Rhino-Orbital Cerebral Mucormycosis with Oral Manifestations: A Retrospective Study2024
  5. 5Survival of Rhino-Orbital-Cerebral Mucormycosis in a Diabetic Patient with Incomplete Surgical Debridement: A Case Report2024